January 27, 2023
Should your clinical trial be adaptive? Trials that include a prospectively planned modification based on an interim..
January 25, 2023
People think in Bayesian terms all the time: we use prior information and the evidence at hand to make decisions in our..
January 23, 2023
Ever since the first immune checkpoint inhibitor was approved for market nearly twelve years ago, the industry has..
January 20, 2023
A small biotech’s conventional carcinoma trial design was too expensive to implement and did not offer the opportunity..
January 17, 2023
When it comes to rare diseases, a handful of major challenges to drug development arise. Bayesians strategies have..
January 13, 2023
Bayesian methods, with their ability to facilitate flexibility and learning, are often associated with early-phase..
January 12, 2023
Statistical methods have long been fundamental to drug development, and advancements in the last few decades in..
January 6, 2023
You may have heard that our clinical trial strategy platform Solara® won the Fierce Life Sciences award for Technology..
January 4, 2023
Returning to Cytel after the winter holidays, I am excited to begin a year that will likely prove memorable for both..